 |
|
|
| |
Everolimus-Facilitated Reduction of Tacrolimus Provides Comparable Efficacy and Superior Renal Function versus Standard Tacrolimus in De Novo Liver Transplant Recipients: 24-month Results of a Randomized Trial
|
| |
| |
Reported by Jules Levin
AASLD Nov 9-13 2012 Boston
Faouzi Saliba1, Paolo De Simone2, Frederik Nevens3, Luciano De Carlis4, Herold J. Metselaar5, Susanne Beckebaum6, Sven Jonas7, Debra Sudan8, Lutz Fischer9, John Fung10, Gaohong Dong11, Patricia Lopez12, Guido Junge12
1Hôpital Paul Brousse, Villejuif, France; 2Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; 3University Hospital Gasthuisberg, KU Leuven, Leuven, Belgium; 4Niguarda "Cà Granda" Hospital, Milan, Italy; 5Erasmus MC, University Hospital Rotterdam, Rotterdam, The Netherlands; 6University Hospital Essen, Essen, Germany; 7University Medical Center Leipzig, Leipzig, Germany; 8Duke University Medical Center, Durham, NC, United States; 9University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; 10Cleveland Clinic Foundation, Cleveland, OH, United States, 11Novartis Pharmaceuticals Corporation, New Jersey, United States, 12Novartis Pharma AG, Basel, Switzerland
|
| |
|
|
|
|
|
